Abstract
Enterobacteriaceae strains having elevated minimal inhibitory concentrations (greater than or equal to 2.0 to less than or equal to 32 micrograms/ml) of cefoperazone, cefotaxime, ceftazidime, and moxalactam were synergistically inhibited by amikacin combinations (54.1 to 69.6% occurrence). Indifference was rare (8.1% for moxalactam), and true antagonistic interactions were not observed. Strains resistant or susceptible to these new cephalosporins were also synergistically inhibited by the addition of amikacin, reducing resistant cephalosporin minimal inhibitory concentrations to clinically achievable levels.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference20 articles.
1. The comparative synergistic activity of amikacin, gentamicin, netilmicin and azlocillin, mezlocillin, carbenicillin and ticarcillin against Serratia marcescens;Fu K. P.;J. Antibiot.,1978
2. Synergistic activity of cefoperazone in combination with P-lactamase inhibitors;Fu K. P.;J. Antimicrob. Chemother.,1980
3. Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing;Fuchs P. C.;Antimicrob. Agents Chemother.,1980
4. Interactions between aminoglycoside antibiotics and carbenicillin or ticarcillin;Holt H. A.;Infection,1976
5. Fortimicin A: collaborative in vitro susceptibility comparison with amikacin and gentamicin against 11,840 clinical bacterial isolates;Jones R. N.;Antimicrob. Agents Chemother.,1979
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献